動画検索
関連広告
検索結果
Opening Remarks
What makes OND the global leader?
NDRP Modernization Objectives
Structure of the Reorganized Office of New Drugs
Office of Therapeutic Biologics and Biosimilars
Divisions within the reorganized structure
Office of Immunology and Inflammation (OII)
IND review management
Future Project Ideas
Closing Remarks
History of the New Drug Regulatory Program Modernization
Intention of the reorganization
Office of Infectious Diseases
Division of Oncology 2
Division of Neurology
Division of Nonmalignant Hematology
Hepatology & Nutrition Division
Division of Urology, Obstetrics & Gynecology
Leadership in Each Division
Post Approval Responsibilities